Drug and medicaldevice companies paid at least  billion to US physicians and teaching hospitals during the final five months of last year according to the most comprehensive accounting so far of the financial ties that some critics say have compromised medical care The figures come from a new federal government transparency initiative The  Affordable Care Act included a provision dubbed the Sunshine Act which requires manufacturers of drugs and medical devices to disclose the payments they make to physicians
  